JPRN-UMIN000013252已完成1 期
WT1 peptide vaccination for pediatric patients: phase I/II study. - WT1 peptide vaccination for pediatric patients:tumor regression study.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 20years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) active infectious diseases 2)Severe Complications, including Heart failure, Renal faiure, Hapatic failure, ileus, uncontrolable DM, and so on 3)Other severe problems unsuitable for this study active infectious diseases
研究者
相似试验
已完成
2 期
Immunotherapy with WT1 peptide vaccine for pediatric patients with bone or soft tissue sarcoma following conventional chemotherapy.Pediatric soft tissue malignancy and neuroblastomaJPRN-UMIN000013251Osaka university graduate school of medicine22
已完成
1 期
WT1 peptide vaccination for patinets with hematological CR after induction chemotherapyCancer vaccineJPRN-UMIN000017937Cancer immunotherapy of Osaka University24
已完成
1 期
Phase I/II clinical trial of WT1 peptide vaccine therapy for lung, breast, pancreas, stomach, and colorectal cancerung, breast, pancreas, stomach, and colorectal cancerJPRN-UMIN000011029Shinshu University50
已完成
不适用
Phase I/II clinical trial of WT1 peptide vaccine for the children with malignanciesJPRN-UMIN000002990Osaka Medical Center and Research Institute for Maternal and Child Health20
已完成
1 期
Phase I clinical trial of WT1 peptide vaccine therapy for pediatric cancersPediatric cancersJPRN-UMIN000011030Shinshu University15